Found: 12
Select item for more details and to access through your institution.
Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2004, v. 20, n. 1, p. 55, doi. 10.1002/dmrr.419
- By:
- Publication type:
- Article
Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0942-x
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus.
- Published in:
- American Journal of Health-System Pharmacy, 2005, v. 62, n. 2, p. 173., doi. 10.1093/ajhp/62.2.173
- By:
- Publication type:
- Article
Effects of exenatide twice daily, exenatide once weekly or insulin in patients with type 2 diabetes and baseline HbA1c ≥10.0%: Two pooled analyses including 20 randomised controlled trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Exenatide once weekly improved 24-hour glucose control and reduced glycaemic variability in metformin-treated participants with type 2 diabetes: a randomized, placebo-controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 40, doi. 10.1111/dom.12763
- By:
- Publication type:
- Article
Effects of Pramlintide on Postprandial Glucose Excursions and Measures of Oxidative Stress in Patients With Type 1 Diabetes.
- Published in:
- Diabetes Care, 2005, v. 28, n. 3, p. 632, doi. 10.2337/diacare.28.3.632
- By:
- Publication type:
- Article
Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.
- Published in:
- 2003
- By:
- Publication type:
- journal article
A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2002, v. 25, n. 4, p. 724, doi. 10.2337/diacare.25.4.724
- By:
- Publication type:
- Article
Onset of Glycemic and Weight Outcomes in Patients Initiating Exenatide Once Weekly: The Relationship of Exenatide Exposure with Efficacy over the First 24 Weeks of Treatment.
- Published in:
- 2016
- By:
- Publication type:
- Report
Dimeric structure of the Oxytricha nova telomere end-binding protein α-subunit bound to ssDNA.
- Published in:
- Nature Structural Biology, 2002, v. 9, n. 3, p. 182
- By:
- Publication type:
- Article
Effect of Pramlintide on Weight in Overweight and Obese Insulin-Treated Type 2 Diabetes Patients<sup>**</sup>.
- Published in:
- Obesity (19307381), 2004, v. 12, n. 4, p. 661, doi. 10.1038/oby.2004.76
- By:
- Publication type:
- Article
6-LB: Effect of Open-Label SGLT2 Inhibitor Treatment When Combined with Exenatide on Cardiovascular and Renal Outcomes in EXSCEL.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-6-LB
- By:
- Publication type:
- Article